Cited by 1,063Genetic factors in colorectal cancerColorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Open access

Vilar, Eduardo, Gruber, Stephen B.·2010·Nature Reviews Clinical Oncology

DOI 10.1038/nrclinonc.2009.237PMC PMC3427139

Open this paper in CoChat — free account

Abstract

Microsatellite instability (MSI) is the molecular fingerprint of a deficient mismatch repair system. Approximately 15% of colorectal cancers (CRC) display MSI owing either to epigenetic silencing of MLH1 or a germline mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2. Methods to detect MSI are well established and routinely incorporated into clinical practice. A clinical and molecular profile of MSI tumors has been described, leading to the concept of an MSI phenotype in CRC. Studies have confirmed that MSI tumors have a better prognosis than microsatellite stable CRC, but MSI cancers do not necessarily have the same response to the chemotherapeutic strategies used to treat microsatellite stable tumors. Specifically, stage II MSI tumors might not benefit from 5-fluorouracil-based adjuvant chemotherapy regimens. New data suggest possible advantages of irinotecan-based regimens, but these findings require further clarification. Characterization of the molecular basis of MSI in CRC is underway and initial results show that mutations in genes encoding kinases and candidate genes with microsatellite tracts are over-represented in MSI tumors. Transcriptome expression profiles of MSI tumors and systems biology approaches are providing the opportunity to develop targeted therapeutics for MSI CRC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nrclinonc.2009.237

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature reviews. Cancer · doi:10.1038/nrc839 · Cited by 6,155
A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Genome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A. F., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,448
Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite Instability
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., de la Chapelle, A., Rüschoff, J., Fishel, R. A., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,181
Microsatellite Instability in Cancer of the Proximal Colon
Thibodeau, S. N., Bren, G. D., & Schaid, D. J. (1993) · Science · doi:10.1126/science.8484122 · Cited by 3,131
Systematic review and meta-analysis
Gillies, A. (2019) · CRC Press eBooks · doi:10.1201/9781315377315-19 · Cited by 2,876
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis
Ionov, Y., Peinado, M. A., Malkhosyan, S. R., Shibata, D. K., & Perucho, M. (1993) · Nature · doi:10.1038/363558a0 · Cited by 2,691
Clues to the Pathogenesis of Familial Colorectal Cancer
Aaltonen, L. A., Peltomäki, P., Leach, F. S., Sistonen, P., Pylkkänen, L., Mecklin, J., Järvinen, H., Powell, S. M., Jen, J., Hamilton, S. R., et al. (1993) · Science · doi:10.1126/science.8484121 · Cited by 2,683
Topoisomerase I inhibitors: camptothecins and beyond
Pommier, Y. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1977 · Cited by 2,362
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Lynch Syndrome Patients with Limited Family History Identified in a Laboratory Setting: A Descriptive Study
Landon, M., Saam, J. R., Brown, K. L., Moyes, K., Evans, B. A., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000430097 · Cited by 1,943
Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
Herman, J. G., Umar, A., Polyák, K., Graff, J. R., Ahuja, N., Issa, J. J., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., Kinzler, K. W., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6870 · Cited by 1,887
Systematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R. A., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,851
Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories
Saam, J. R., Arnell, C., Theisen, A. P., Moyes, K., Marino, I., Roundy, K. M., & WENSTRUP, R. J. (2015) · Oncology · doi:10.1159/000437307 · Cited by 1,533
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer
Gryfe, R., Kim, H., Hsieh, E., Aronson, M. D., Holowaty, E. J., Bull, S. B., Redston, M. S., & Gallinger, S. (2000) · New England Journal of Medicine · doi:10.1056/nejm200001133420201 · Cited by 1,396
The multifaceted mismatch-repair system
Jiricny, J. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1907 · Cited by 1,375
Allelotype of Colorectal Carcinomas
Vogelstein, B., Fearon, E. R., Kern, S. E., Hamilton, S. R., Preisinger, A. C., Nakamura, Y., & White, R. L. (1989) · Science · doi:10.1126/science.2565047 · Cited by 1,302
RAF/RAS oncogenes and mismatch-repair status
Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature · doi:10.1038/418934a · Cited by 1,224
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Roth, A. D., Tejpar, S., Delorenzi, M., Yan, P., Fiocca, R., Klingbiel, D., Dietrich, D., Biesmans, B., Bodoky, G., Barone, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.3452 · Cited by 1,178
Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease
Aaltonen, L. A., Salovaara, R., Kristo, P., Canzian, F., Hemminki, A., Peltomäki, P., Chadwick, R. B., Kääriäinen, H., Eskelinen, M. J., Järvinen, H., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805213382101 · Cited by 1,141
The Genetic Basis of Human Cancer
Vogelstein, B., & Kinzler, K. W. (1997) · Cited by 1,120
Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer
Watanabe, T., Wu, T., Catalano, P. J., Ueki, T., Satriano, R., Haller, D. G., Benson, A. B., & Hamilton, S. R. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104193441603 · Cited by 881
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818
Kirsten ras mutations in patients with colorectal cancer: The multicenter “RASCAL” study
Andreyev, H. J. N., Norman, A. R., Clarke, P. A., Cunningham, D., & Oates, J. R. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.675 · Cited by 748
PIK3CA Mutations in Colorectal Cancer Are Associated with Clinical Resistance to EGFR-Targeted Monoclonal Antibodies
Sartore-Bianchi, A., Martini, M., Molinari, F., Veronese, S., Nichelatti, M., Artale, S., Di Nicolantonio, F., Saletti, P., De Dosso, S., Mazzucchelli, L., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2466 · Cited by 739
Colon Cancer
Engstrom, P. F., Arnoletti, J. P., Benson, A. B., Chen, Y., Choti, M. A., Cooper, H. S., Covey, A. M., Dilawari, R. A., Early, D. S., Enzinger, P. C., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0056 · Cited by 683
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Koopman, M., Antonini, N. F., Douma, J., Wals, J., Honkoop, A. H., Erdkamp, F., de Jong, R. S., Rodenburg, C. J., Vreugdenhil, G., Loosveld, O. J. L., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61086-1 · Cited by 629
Development of the 21-Gene Assay and Its Application in Clinical Practice and Clinical Trials
Sparano, J. A., & Paik, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1068 · Cited by 622
Mutations in a signalling pathway
Parsons, D. W., Wang, T., Samuels, Y., Bardelli, A., Cummins, J. M., Wood, L. D., Silliman, N., Ptak, J., Szabo, S., Willson, J. K. V., et al. (2005) · Nature · doi:10.1038/436792a · Cited by 599
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer
Elsaleh, H., Joseph, D. J., Grieu, F., Zeps, N., Spry, N. A., & Iacopetta, B. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02261-3 · Cited by 553
Accuracy of Revised Bethesda Guidelines, Microsatellite Instability, and Immunohistochemistry for the Identification of Patients With Hereditary Nonpolyposis Colorectal Cancer
Piñol, V. (2005) · JAMA · doi:10.1001/jama.293.16.1986 · Cited by 528
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
Koopman, M., Kortman, G. A. M., Mekenkamp, L. J., Ligtenberg, M. J. L., Hoogerbrugge, N., Antonini, N. F., Punt, C. J. A., & van Krieken, J. H. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604867 · Cited by 521
Population-Based Molecular Detection of Hereditary Nonpolyposis Colorectal Cancer
Salovaara, R., Loukola, A., Kristo, P., Kääriäinen, H., Ahtola, H., Eskelinen, M. J., Härkönen, N., Julkunen, R. J. K., Kangas, E., Ojala, S., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.11.2193 · Cited by 510
Clinical Application of the 70-Gene Profile: The MINDACT Trial
Cardoso, F., Veer, L. V., Rutgers, E. J. T., Loi, S., Mook, S., & Piccart, M. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3222 · Cited by 467
Mismatch repair proficiency and in vitro response to 5-fluorouracil
Carethers, J. M., Chauhan, D. P., Fink, D. A., Nebel, S., Bresalier, R. S., Howell, S. B., & Boland, C. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70558-5 · Cited by 430
BRAF Mutation Is Frequently Present in Sporadic Colorectal Cancer with Methylated hMLH1, But Not in Hereditary Nonpolyposis Colorectal Cancer
Deng, G., Bell, I., Crawley, S., Gum, J. R., Terdiman, J. P., Allen, B. A., Truta, B., Sleisenger, M. H., & Kim, Y. S. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1118-3 · Cited by 404
The Genetic Basis of Human Cancer
Rubin, C. M. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-9-199811010-00045 · Cited by 403
Mutations at coding repeat sequences in mismatch repair-deficient human cancers: toward a new concept of target genes for instability.
Duval, A., & Hamelin, R. (2002) · PubMed · Cited by 398
Prediction of Germline Mutations and Cancer Risk in the Lynch Syndrome
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., Watson, P. A., Gruber, S. B., Euhus, D., Kinzler, K. W., et al. (2006) · JAMA · doi:10.1001/jama.296.12.1479 · Cited by 385
Self-citation
Microsatellite instability and colorectal cancer prognosis
Benatti, P., Gafà, R., Barana, D., Marino, M., Scarselli, A., Pedroni, M., Maestri, I., Guerzoni, L., Roncucci, L., Menigatti, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1030 · Cited by 379
Microsatellite Instability Predicts Improved Response to Adjuvant Therapy With Irinotecan, Fluorouracil, and Leucovorin in Stage III Colon Cancer: Cancer and Leukemia Group B Protocol 89803
Bertagnolli, M. M., Niedzwiecki, D., Compton, C. C., Hahn, H. P., Hall, M., Damas, B. C., Jewell, S. D., Mayer, R. J., Goldberg, R. M., Saltz, L. B., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.2071 · Cited by 364
Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
Stoffel, E., Mukherjee, B., Raymond, V. M., Tayob, N., Kastrinos, F., Sparr, J., Wang, F., Bandipalliam, P., Syngal, S., & Gruber, S. B. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.039 · Cited by 360
Self-citation
Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
Hemminki, A., Mecklin, J., Järvinen, H., Aaltonen, L. A., & Joensuu, H. (2000) · Gastroenterology · doi:10.1053/gast.2000.18161 · Cited by 353
Mutations in the RAS‐MAPK, PI(3)K (phosphatidylinositol‐3‐OH kinase) signaling network correlate with poor survival in a population‐based series of colon cancers
Barault, L., Veyrie, N., Jooste, V., Corre, D. L., Chapusot, C., Ferraz, J., Lièvre, A., Cortet, M., Bouvier, A., Rat, P., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23388 · Cited by 352
Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study
Kim, G. P., Colangelo, L. H., Wieand, H. S., Paik, S., Kirsch, I. R., Wolmark, N., & Allegra, C. J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.8172 · Cited by 341
BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing
Domingo, E., Laiho, P., Ollikainen, M., Pinto, M., Wang, L., French, A. J., Westra, J., Frébourg, T., Espín, E., Armengol, M., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.020651 · Cited by 339
PIK3CA Mutation Is Associated With Poor Prognosis Among Patients With Curatively Resected Colon Cancer
Ogino, S., Nosho, K., Kirkner, G. J., Shima, K., Irahara, N., Kure, S., Chan, A. T., Engelman, J. A., Kraft, P. L., Cantley, L. C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.6544 · Cited by 331
Frequent Inactivation of PTEN by Promoter Hypermethylation in Microsatellite Instability-High Sporadic Colorectal Cancers
Goel, A., Arnold, C. N., Niedzwiecki, D., Carethers, J. M., Dowell, J. M., Wasserman, L., Compton, C., Mayer, R. J., Bertagnolli, M. M., & Boland, C. R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-2401-2 · Cited by 302
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
Ropero, S., Fraga, M. F., Ballestar, E., Hamelin, R., Yamamoto, H., Boix-Chornet, M., Caballero, R., Alaminos, M., Setién, F., Paz, M. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1773 · Cited by 300
Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysis
Guetz, G. D., Schischmanoff, P. O., Nicolas, P., Perret, G. Y., Morère, J., & Uzzan, B. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.04.018 · Cited by 291
BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang, L., Cunningham, J. M., Winters, J. L., Guenther, J. C., French, A. J., Boardman, L. A., Burgart, L. J., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (2003) · PubMed · Cited by 280
CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.
van Rijnsoever, M., Elsaleh, H., Joseph, D. J., McCaul, K. A., & Iacopetta, B. J. (2003) · PubMed · Cited by 267
Phenotype of Microsatellite Unstable Colorectal Carcinomas: Well-Differentiated and Focally Mucinous Tumors and the Absence of Dirty Necrosis Correlate With Microsatellite Instability
Greenson, J. K., Bonner, J. D., Ben-Yzhak, O., Cohen, H. I., Miselevich, I., Resnick, M. B., Trougouboff, P., Tomsho, L. D., Kim, A. A., Low, M., et al. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200305000-00001 · Cited by 249
Self-citation
Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
Fallik, D., Borrini, F., Boige, V., Viguier, J., Jacob, S., Miquel, C., Sabourin, J., Ducreux, M. P., & Praz, F. (2003) · PubMed · Cited by 232
Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer
Jover, R., Zapater, P., Castells, A., Llor, X., Andreu, M. G., Cubiella, J., Piñol, V., Xicola, R. M., Bujanda, L., Reñé, J. M., et al. (2005) · Gut · doi:10.1136/gut.2005.073015 · Cited by 231
Promoter Hypermethylation Frequency and BRAF Mutations Distinguish Hereditary Non-Polyposis Colon Cancer from Sporadic MSI-H Colon Cancer
McGivern, A., Wynter, C. V. A., Whitehall, V., Kambara, T., Spring, K. J., Walsh, M. D., Barker, M., Arnold, S., Simms, L. A., Leggett, B., et al. (2004) · Familial Cancer · doi:10.1023/b:fame.0000039861.30651.c8 · Cited by 205
Diagnostic Approach and Management of Lynch Syndrome (Hereditary Nonpolyposis Colorectal Carcinoma): A Guide for Clinicians
Hendriks, Y. M. C., Jong, A. E. V. D. M., Morreau, H. M., Tops, C. M. J., Vasen, H. F. A., Wijnen, J., Breuning, M. H., & Bröcker-Vriends, A. H. J. T. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.4.213 · Cited by 176
The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
Jacob, S., Aguado, M., Fallik, D., & Praz, F. (2001) · PubMed · Cited by 172
Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity.
Banerjea, A., Ahmed, S., Hands, R. E., Huang, F., Han, X., Shaw, P. M., Feakins, R. M., Bustin, S. A., & Dorudi, S. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-21 · Cited by 152
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency
Oliveíra, C., Pinto, M., Duval, A., Louis‐Brennetot, C., Domingo, E., Espín, E., Armengol, M., Yamamoto, H., Hamelin, R., Seruca, R., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1207061 · Cited by 151
Systematic Review and Meta-analysis of Ovarian Cancers: Estimation of Microsatellite-High Frequency and Characterization of Mismatch Repair Deficient Tumor Histology
Pal, T., Permuth‐Wey, J., Kumar, A., & Sellers, T. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1387 · Cited by 150
PIK3CAmutation is predictive of poor survival in patients with colorectal cancer
Kato, S., Iida, S., Higuchi, T., Ishikawa, T., Takagi, Y., Yasuno, M., Enomoto, M., Uetake, H., & Sugihara, K. (2007) · International Journal of Cancer · doi:10.1002/ijc.22890 · Cited by 147
Phosphorylation of extracellular signal-regulated kinase 1 and 2, protein kinase B, and signal transducer and activator of transcription 3 are differently inhibited by an epidermal growth factor receptor inhibitor, EKB-569, in tumor cells and normal human keratinocytes
Nunes, M., Shi, C., & Greenberger, L. M. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.21.3.1 · Cited by 145
Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas
Koinuma, K., Shitoh, K., Miyakura, Y., Furukawa, T., Yamashita, Y., Ota, J., Ohki, R., Choi, Y. L., Wada, T., Konishi, F., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11523 · Cited by 134
Distal Colorectal Cancers with Microsatellite Instability (MSI) Display Distinct Gene Expression Profiles that Are Different from Proximal MSI Cancers
Watanabe, T., Kobunai, T., Toda, E., Yamamoto, Y., Kanazawa, T., Kazama, Y., Tanaka, J., Tanaka, T., Konishi, T., Okayama, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1163 · Cited by 126
Associations between Smoking, Alcohol Consumption, and Colorectal Cancer, Overall and by Tumor Microsatellite Instability Status
Poynter, J. N., Haile, R. W., Siegmund, K. D., Campbell, P. T., Figueiredo, J. C., Limburg, P. J., Young, J. P., Marchand, L. L., Potter, J. D., Cotterchio, M., et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0517 · Cited by 124
Cellular effects of CPT‐11 on colon carcinoma cells: Dependence on p53 and hMLH1 status
Magrini, R., Bhonde, M., Hanski, M., Notter, M., Scherübl, H., Boland, C. R., Zeitz, M., & HANSKI, C. (2002) · International Journal of Cancer · doi:10.1002/ijc.10565 · Cited by 121
Frequent alteration of DNA damage signalling and repair pathways in human colorectal cancers with microsatellite instability
Miquel, C., Jacob, S., Grandjouan, S., Aimé, A., Viguier, J., Sabourin, J., Sarasin, A. R., Duval, A., & Praz, F. (2007) · Oncogene · doi:10.1038/sj.onc.1210419 · Cited by 120
High‐frequency microsatellite instability predicts better chemosensitivity to high‐dose 5‐fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
Liang, J., Huang, K., Lai, H., Lee, P., Cheng, Y., Hsu, H., Cheng, A., Hsu, C., Yeh, K., Wang, S., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10643 · Cited by 120
DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers
Jorissen, R. N., Lipton, L. R., Gibbs, P., Chapman, M., Desai, J., Jones, I. T., Yeatman, T. J., East, P., Tomlinson, I. P. M., Verspaget, H. W., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1431 · Cited by 114
High incidence of microsatellite instability in colorectal cancer from African Americans.
Ashktorab, H., Smoot, D. T., Carethers, J. M., Rahmanian, M., Kittles, R. A., Vosganian, G., Doura, M., Nidhiry, E., Naab, T., Momen, B., et al. (2003) · PubMed · Cited by 110
Mutations of an intronic repeat induce impaired MRE11 expression in primary human cancer with microsatellite instability
Giannini, G., Rinaldi, C., Ristori, E., Ambrosini, M. I., Cerignoli, F., Viel, A., Bidoli, E., Berni, S., d’Amati, G., Scambia, G., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207409 · Cited by 109
Differences and evolution of the methods for the assessment of microsatellite instability
Laghi, L., Bianchi, P. P., & Malesci, A. (2008) · Oncogene · doi:10.1038/onc.2008.217 · Cited by 103
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
Soliman, A. S., Bondy, M. L., El-Badawy, S. A., Mokhtar, N., Eissa, S., Bayoumy, S., Seifeldin, I. A., Houlihan, P., Lukish, J. R., Watanabe, T., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1838 · Cited by 100
Interpretation of microarray data in cancer
Michiels, S., Koscielny, S., & Hill, C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603673 · Cited by 98
Microsatellite instability (MSI) in stage II and III colon cancer treated with 5FU-LV or 5FU-LV and irinotecan (PETACC 3-EORTC 40993-SAKK 60/00 trial)
Tejpar, S., Bosman, F. T., Delorenzi, M., Fiocca, R., Yan, P., Klingbiel, D., Dietrich, D., Cutsem, E. V., Labianca, R., & Roth, A. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.4001 · Cited by 94
Clinicopathological analysis of colorectal cancers with PIK3CA mutations in Middle Eastern population
Abubaker, J. A., Bavi, P. P., Al-harbi, S., Ibrahim, M., Siraj, A. K., Al-Sanea, N. A., Abduljabbar, A. B., Ashari, L. H. S., Alhomoud, S. J., Al‐Dayel, F., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211013 · Cited by 93
A Prospective, Multicenter, Population-Based Study of BRAF Mutational Analysis for Lynch Syndrome Screening
Bessa, X., Ballesté, B., Andreu, M. G., Castells, A., Bellosillo, B., Balaguer, F., Castellvı́-Bel, S., Payá, A., Jover, R., Alenda, C., et al. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.10.011 · Cited by 91
Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines
Vilar, E., Scaltriti, M., Balmañà, J., Saura, C., Guzmán, M., Arribas, J., Baselga, J. M., & Tabernero, J. M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604691 · Cited by 91
Self-citation
Confirmation of deficient mismatch repair (dMMR) as a predictive marker for lack of benefit from 5-FU based chemotherapy in stage II and III colon cancer (CC): A pooled molecular reanalysis of randomized chemotherapy trials
Sargent, D. J., Marsoni, S., Thibodeau, S. N., Labianca, R., Hamilton, S. R., Torri, V., Monges, G., Ribic, C. M., Grothey, A. A., & Gallinger, S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4008 · Cited by 91
Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysis.
Guetz, G. D., Uzzan, B., Nicolas, P., Schischmanoff, P. O., Perret, G. Y., & Morère, J. (2009) · PubMed · Cited by 90
PIK3CAcancer mutations display gender and tissue specificity patterns
Benvenuti, S., Frattini, M., Arena, S., Zanon, C., Cappelletti, V., Coradini, D., Daidone, M. G., Pilotti, S., Pierotti, M. A., & Bardelli, A. (2007) · Human Mutation · doi:10.1002/humu.20648 · Cited by 87
Novel TET2 Mutations Associated With UPD4q24 in Myelodysplastic Syndrome
Mohamedali, A. M., Smith, A., Gäken, J. A., Lea, N. C., Mian, S. A., Westwood, N., Strupp, C., Gattermann, N., Germing, U., & Mufti, G. J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6985 · Cited by 84
Hypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases.
Nagasaka, T., Sharp, G. B., Notohara, K., Kambara, T., Sasamoto, H., Isozaki, H., MacPhee, D. G., Jass, J. R., Tanaka, N., & Matsubara, N. (2003) · PubMed · Cited by 84
Gene expression signatures for colorectal cancer microsatellite status and HNPCC
Kruhøffer, M., Jensen, J. L., Laiho, P., Dyrskjøt, L., Salovaara, R., Arango, D., Birkenkamp‐Demtröder, K., Sørensen, F. B., Christensen, L.-L., Buhl, L., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602621 · Cited by 77
A Gene Expression Signature of Genetic Instability in Colon Cancer
Giacomini, C. P., Leung, S. Y., Chen, X., Yuen, S. T., Kim, Y. H., Bair, E., & Pollack, J. R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4163 · Cited by 73
Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
Kumar, K., Brim, H., Giardiello, F. M., Smoot, D. T., Nouraie, M. S., Lee, E. L., & Ashktorab, H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1029 · Cited by 73
Molecular classification of solid tumours: towards pathway-driven therapeutics
Swanton, C., & Caldas, C. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605031 · Cited by 71
Microsatellite instability did not predict individual survival of unselected patients with colorectal cancer
Lamberti, C., Lundin, S., Bogdanow, M., Pagenstecher, C., Friedrichs, N., Büttner, R., & Sauerbruch, T. (2006) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0131-8 · Cited by 66
New Developments in Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer) and Mismatch Repair Gene Testing
Gruber, S. B. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.01.031 · Cited by 66
Self-citation
Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway
Vilar, E., Mukherjee, B., Kuick, R. D., Raskin, L., Misek, D. E., Taylor, J. M. G., Giordano, T. J., Hanash, S., Fearon, E. R., Rennert, G., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2432 · Cited by 66
Self-citation
Phosphatase Protein Homologue to Tensin Expression and Phosphatidylinositol-3 Phosphate Kinase Mutations in Colorectal Cancer
Frattini, M., Signoroni, S., Pilotti, S., Bertario, L., Benvenuti, S., Zanon, C., Bardelli, A., & Pierotti, M. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2780 · Cited by 47
Adjuvant Therapy in Stage II Colon Cancer: Current Approaches
Baddi, L., & Benson, A. B. (2005) · The Oncologist · doi:10.1634/theoncologist.10-5-325 · Cited by 42
Thymidine Selectively Enhances Growth Suppressive Effects of Camptothecin/Irinotecan in MSI+ Cells and Tumors Containing a Mutation of MRE11
Rodrı́guez, R., Hansen, L. T., Phear, G. A., Scorah, J., Spang‐Thomsen, M., Cox, A., Helleday, T., & Meuth, M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0274 · Cited by 42
Preclinical testing of the PARP inhibitor ABT-888 in microsatellite instable colorectal cancer
Sanchez, E. V., Chow, A., Raskin, L., Iniesta, M. D., Mukherjee, B., & Gruber, S. B. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.11028 · Cited by 12
Self-citation

Sorted by citations

Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Molecular Genetics of Colorectal Cancer
Fearon, E. R. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130235 · Cited by 1,805
Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
Behan, F. M., Iorio, F., Picco, G., Gonçalves, E., Beaver, C. M., Migliardi, G., Santos, R., Rao, Y., Sassi, F., Pinnelli, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1103-9 · Cited by 1,338
Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction
Mlecnik, B., Tosolini, M., Kirilovsky, A., Berger, A., Bindea, G., Meatchi, T., Bruneval, P., Trajanoski, Z., Fridman, W.-H., Pagès, F., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5425 · Cited by 1,009
Classification and characterization of microsatellite instability across 18 cancer types
Hause, R. J., Pritchard, C. C., Shendure, J., & Salipante, S. J. (2016) · Nature Medicine · doi:10.1038/nm.4191 · Cited by 982

See all 1,063

Authors: Vilar, E., & Gruber, S. B.
Affiliations: University of Michigan (US)
Corresponding author: Gruber, Stephen B.
ORCID: Vilar, Eduardo
Gruber, Stephen B.
Venue: Nature Reviews Clinical Oncology
Publisher: Springer Science and Business Media LLC
Published: 2010-02-09
Volume: 7
Issue: 3
Pages: 153-162
ISSN: 1759-4774 (ISSN-L)
1759-4782
DOI: 10.1038/nrclinonc.2009.237
PMC: PMC3427139
OpenAlex: W2050658928
Cited by: 1,063
References: 100
Citations by year: 2026: 57 · 2025: 100 · 2024: 116 · 2023: 114 · 2022: 99 · 2021: 81 · 2020: 75 · 2019: 65 · 2018: 66 · 2017: 46 · 2016: 34 · 2015: 47 · 2014: 44 · 2013: 44 · 2012: 28
FWCI: 4.61
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Reviews Clinical Oncology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (5P30 CA 46592, 1R01CA81488, R01CA081488, P30CA046592)
Topics: Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
Keywords: microsatellite instability, colorectal cancer, mismatch repair deficiency, prognosis, predictive biomarkers, irinotecan, kinase mutations, targeted therapy
MeSH terms: DNA Repair, Humans, Colorectal Neoplasms, Germ-Line Mutation, DNA Repair Enzymes, Microsatellite Instability

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Microsatellite Instability in Colorectal Cancer-the Stable Evidence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks